S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Impax Laboratories Reports Second Quarter 2013 Results (2013/8/8)|
|Impax Laboratories to Present at the Canaccord Genuity Annual Growth Conference ()|
|Impax Laboratories and TOLMAR, Inc. Announce Final FDA Approval for Generic Solaraze® Gel (Diclofenac Sodium-3%) ()|
|Impax Laboratories Announces OxyContin® Patent Challenge Settlement ()|
|Impax Laboratories Reports Fourth Quarter and Full Year 2013 Results (2014/2/20)|
|Impax Laboratories Confirms Patent Challenge Relating to Generic Atelvia® Delayed-Release Tablets, 35 mg ()|
|Impax Laboratories Launches Generic Solaraze® (Diclofenac Sodium Gel, 3%) ()|
|Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2013 Financial Results ()|
|Impax Laboratories to Present at the 2013 Credit Suisse Healthcare Conference on November 14 ()|
|Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3 ()|
Click above to view more mutual fund data and stats for ipxl - Impax Laboratories, Inc..